Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).
Status:
Recruiting
Trial end date:
2020-12-20
Target enrollment:
Participant gender:
Summary
This is a bicentric, phase 2, randomized, open-label study to evaluate the efficacy and
safety of maraviroc associated with standard treatment in hospitalized patients with
pulmonary SARS-CoV-2 infection (COVID-19).
Phase:
Phase 2
Details
Lead Sponsor:
Hospital Universitario Infanta Leonor
Collaborators:
Hospital Clínic de Barcelona Hospital Clinic of Barcelona ViiV Healthcare